Recent Posts

jCyte Inc. Announces Presentation of Phase 2b Results Evaluating jCell in Retinitis Pigmentosa at the American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting July 7, 2020 - July 7th, 2020 NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- jCyte Inc., a biotech company dedicated to preserving andrestoring vision in patients with retinitis pigmentosa and other degenerative retinal disorders, announced todaythat results from the Phase 2b clinical… Read More >
jCyte Inc. Announces Scientific Advisory Board with Distinguished Retinal Physicians June 30, 2020 - NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- jCyte Inc., a biotech company dedicated to improving thelives of patients with rare degenerative retinal diseases, announced today its Scientific Advisory Board (SAB)comprised of world-renowned retinal physicians to provide external scientific… Read More >
UCI Startup Company jCyte Partners with Santen Pharmaceutical June 4, 2020 - UCI Beall Applied Innovation June 4, 2020 By Ethan Perez UCI company jCyte, Inc. has formalized an exclusive licensing contract with Japanese pharmaceutical company Santen Pharmaceutical. jCyte, founded by Dr. Henry Klassen and Dr. Jing Yang of UC Irvine’s School… Read More >